Miscellaneous
Background: Baloxavir (trade name Xofluza) was approved for the treatment of acute, uncomplicated influenza in patients > 12 years of age in October 2018. However,... The post REBEL Cast Ep86: Baloxavir for Influenza Prophylaxis appeared first on REBEL EM - Emergency Medicine Blog.